BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 32080744)

  • 1. The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction.
    Himes BT; Peterson TE; de Mooij T; Garcia LMC; Jung MY; Uhm S; Yan D; Tyson J; Jin-Lee HJ; Parney D; Abukhadra Y; Gustafson MP; Dietz AB; Johnson AJ; Dong H; Maus RL; Markovic S; Lucien F; Parney IF
    Neuro Oncol; 2020 Jul; 22(7):967-978. PubMed ID: 32080744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-γ through PD-L1 and IDO1.
    Jung MY; Aibaidula A; Brown DA; Himes BT; Cumba Garcia LM; Parney IF
    Neurooncol Adv; 2022; 4(1):vdac017. PubMed ID: 35990703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of heparin to rescue immunosuppressive monocyte reprogramming by glioblastoma-derived extracellular vesicles.
    Himes BT; Fain CE; Tritz ZP; Nesvick CL; Jin-Lee HJ; Geiger PA; Peterson TE; Jung MY; Parney IF
    J Neurosurg; 2023 May; 138(5):1291-1301. PubMed ID: 36115048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.
    Ricklefs FL; Alayo Q; Krenzlin H; Mahmoud AB; Speranza MC; Nakashima H; Hayes JL; Lee K; Balaj L; Passaro C; Rooj AK; Krasemann S; Carter BS; Chen CC; Steed T; Treiber J; Rodig S; Yang K; Nakano I; Lee H; Weissleder R; Breakefield XO; Godlewski J; Westphal M; Lamszus K; Freeman GJ; Bronisz A; Lawler SE; Chiocca EA
    Sci Adv; 2018 Mar; 4(3):eaar2766. PubMed ID: 29532035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling.
    Fleming V; Hu X; Weller C; Weber R; Groth C; Riester Z; Hüser L; Sun Q; Nagibin V; Kirschning C; Bronte V; Utikal J; Altevogt P; Umansky V
    Cancer Res; 2019 Sep; 79(18):4715-4728. PubMed ID: 31337655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling.
    Arkhypov I; Özbay Kurt FG; Bitsch R; Novak D; Petrova V; Lasser S; Hielscher T; Groth C; Lepper A; Hu X; Li W; Utikal J; Altevogt P; Umansky V
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36113897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth.
    Lamano JB; Lamano JB; Li YD; DiDomenico JD; Choy W; Veliceasa D; Oyon DE; Fakurnejad S; Ampie L; Kesavabhotla K; Kaur R; Kaur G; Biyashev D; Unruh DJ; Horbinski CM; James CD; Parsa AT; Bloch O
    Clin Cancer Res; 2019 Jun; 25(12):3643-3657. PubMed ID: 30824583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-Derived Suppressive Cells Promote B cell-Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma.
    Lee-Chang C; Rashidi A; Miska J; Zhang P; Pituch KC; Hou D; Xiao T; Fischietti M; Kang SJ; Appin CL; Horbinski C; Platanias LC; Lopez-Rosas A; Han Y; Balyasnikova IV; Lesniak MS
    Cancer Immunol Res; 2019 Dec; 7(12):1928-1943. PubMed ID: 31530559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer.
    Li YD; Lamano JB; Lamano JB; Quaggin-Smith J; Veliceasa D; Kaur G; Biyashev D; Unruh D; Bloch O
    Cancer Immunol Immunother; 2019 Sep; 68(9):1501-1513. PubMed ID: 31489465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles containing PD-L1 contribute to CD8+ T-cell immune suppression and predict poor outcomes in small cell lung cancer.
    Dou X; Hua Y; Chen Z; Chao F; Li M
    Clin Exp Immunol; 2022 May; 207(3):307-317. PubMed ID: 35553630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
    Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
    Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Checkpoint Inhibition in GBM Primed with Radiation by Engineered Extracellular Vesicles.
    Tian T; Liang R; Erel-Akbaba G; Saad L; Obeid PJ; Gao J; Chiocca EA; Weissleder R; Tannous BA
    ACS Nano; 2022 Feb; 16(2):1940-1953. PubMed ID: 35099172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma.
    Anderson HG; Takacs GP; Harris DC; Kuang Y; Harrison JK; Stepien TL
    J Math Biol; 2023 Dec; 88(1):10. PubMed ID: 38099947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes.
    Beez CM; Haag M; Klein O; Van Linthout S; Sittinger M; Seifert M
    J Nanobiotechnology; 2019 May; 17(1):72. PubMed ID: 31133024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M-MDSCs mediated trans-BBB drug delivery for suppression of glioblastoma recurrence post-standard treatment.
    Yu T; Wang K; Wang J; Liu Y; Meng T; Hu F; Yuan H
    J Control Release; 2024 May; 369():199-214. PubMed ID: 38537717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-mediated blockade of CXCL12/CXCR4 signaling enhances glioblastoma immunotherapy: Monitoring early responses with MRI radiomics.
    Wei R; Li J; Lin W; Pang X; Yang H; Lai S; Wei X; Jiang X; Yuan Y; Yang R
    Acta Biomater; 2024 Mar; 177():414-430. PubMed ID: 38360292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EV PD-L1 is Correlated With Clinical Features and Contributes to T Cell Suppression in Pediatric Thyroid Cancer.
    Wang G; He L; Wang S; Zhang M; Li Y; Liu Q; Sun N; Zhang X; Liu Y; Zhang J; Tai J; Ni X
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32459310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic glioblastoma-cell-derived extracellular vesicles impair cGAS-STING activity in macrophages.
    Tankov S; Petrovic M; Lecoultre M; Espinoza F; El-Harane N; Bes V; Chliate S; Bedoya DM; Jordan O; Borchard G; Migliorini D; Dutoit V; Walker PR
    Cell Commun Signal; 2024 Feb; 22(1):144. PubMed ID: 38389103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages.
    Liu Y; Lu M; Chen J; Li S; Deng Y; Yang S; Ou Q; Li J; Gao P; Luo Z; Yuan P; Tan J; Gao X
    Sleep Breath; 2022 Jun; 26(2):893-906. PubMed ID: 34254261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.